Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin

Cancer Nanotechnology

Volumn 3, Issue 1-6, 2012, Pages 65-81

  Mulik, Rohit S ^a,c,d   Mönkkönen, Jukka ^c   Juvonen, Risto O ^c   Mahadik, Kakasaheb R ^a   Paradkar, Anant R ^b  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Curcumin; Flow cytometry; Neuroblastoma; Solid lipid nanoparticles

Indexed keywords

CURCUMIN; REACTIVE OXYGEN METABOLITE; SOLID LIPID NANOPARTICLE; SURFACTANT; TRANSFERRIN CONJUGATED SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG RELEASE; ENTRAPMENT EFFICIENCY; ENZYME ACTIVATION; ENZYME ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; PHOTOSTABILITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 84870333974     PISSN: 18686958     EISSN: 18686966     Source Type: Journal    
DOI: 10.1007/s12645-012-0031-2     Document Type: Article

References (54)

1. Adrian JE, Wolf A, Steinbach A, Rössler J, Süss R (2011) Targeted delivery to neuroblastoma of novel siRNA-anti-GD2-liposomes prepared by dual asymmetric centrifugation and sterol-based post-insertion method. Pharm Res 28(9): 2261-2272.
2. Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases. Int J Biochem Cell Biol 41: 40-59.
3. Aggarwal BB, Kumar A, Bharti A (2003a) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398.
4. Aggarwal B, Swaroop P, Protiva P, Raj SV, Shirin H, Holt PR (2003b) Cox-2 is needed but not sufficient for apoptosis induced by Cox-selective inhibitors in colon cancer cells. Apoptosis 8: 649-654.
5. Aggarwal BB, Kumar A, Aggarwal MS, Shishodia S (2005a) Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. In: Preuss HG (ed) Phytopharmaceuticals in cancer chemoprevention. CRC, Boca Raton, pp 349-387.
6. Aggarwal BB, Shishodia S, Takada Y (2005b) Curcumin suppresses the paclitaxel-induced nuclear factor-{kappa}B pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-7498.
7. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818.
8. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB (2008) Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 267: 133-164.
9. Ansari MJ, Ahmad S, Kohli K, Ali J, Khar RK (2005) Stability indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations. J Pharm Biomed Anal 39: 132-138.
10. Azuine MA, Bhide SV (1992) Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer 17: 77-83.
11. Bong PH (2000) Spectral and photophysical behaviors of curcumin and curcuminoids. Bull Korean Chem Soc 21(1): 81-86.
12. Bradford MA (1976) Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
13. Buttke TM, Sandstrom PM (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7-10.
14. Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK (2004) Turmeric and curcumin: biological actions and medicinal applications. Curr Sci 87: 44-53.
15. Chearwae W, Anuchapreeda S, Nandigama K, Ambudkar SV, Limtrakul P (2004) Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from turmeric powder. Biochem Pharmacol 68: 2043-2052.
16. Chearwae W, Wu CP, Chu HY, Lee TR, Ambudkar SV, Limtrakul P (2006) Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother Pharmacol 57: 376-388.
17. Christine SA, Kumari L, Khar A (2004) Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 3: 1101-1108.
18. Dehal PK, Embleton MJ, Kemshead JT, Hawkins RE (2002) Targeted cytokine delivery to neuroblastoma. Biochem Soc Trans 30(4): 518-520.
19. Di Paolo D et al (2011) Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK. Mol Ther 19(6): 1131-1140.
20. Dilnawaz F, Singh A, Sahoo SK (2012) Transferrin-conjugated curcumin-loaded superparamagnetic iron oxide nanoparticles induce augmented cellular uptake and apoptosis in K562 cells. Acta Biomater 8: 704-719.
21. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE (2001) Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47: 293-303.
22. Ganta S, Amiji M (2009) Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 6: 928-939.
23. Gupta Y, Jain A, Jain SK (2007) Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Pharm Pharmacol 59: 935-940.
24. Gutman RL, Peacock G, Lu R (2000) Targeted drug delivery for brain cancer treatment. J Control Release 65: 31-41.
25. Jacobson MD (1996) Reactive oxygen species and programmed cell death. Trends Biochem Sci 21: 83-86.
26. Jenning V, Korting MS, Gohla S (2000) Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 66: 115-126.
27. Joe B, Vijaykumar M, Lokesh BR (2004) Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44: 97-111.
28. Kunwar A, Barik A, Mishra B, Rathinasamy K, Pandey R, Priyadarsini KI (2008) Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochem Biophys Acta 1780: 673-679.
29. Lemieux P, Page M (1994) Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate. Anticancer Res 14: 397-403.
30. Li JL, Wanga L, Liu XY (2009) In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett 274: 319-326.
31. Martell LA, Agrawal A, Ross DA, Muraszko KM (1993) Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res 53(6): 1348-1353.
32. Maruyama K, Ishida O, Kasaoka S (2004) Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). J Control Release 98: 195-207.
33. Mulik R, Mahadik KR, Paradkar AR (2009) Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: physicochemical characterization and stability study. Eur J Pharm Sci 37: 395-404.
34. Mulik RS, Mönkkönen J, Juvonen RO, Mahadik KR, Paradkar AR (2010) Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm 398: 190-203.
35. Padamwar MN, Pokharkar VB (2006) Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int J Pharm 320: 37-44.
36. Page-Clisson ME, Pinto HA, Ourevitch M, Andremont A, Couvreur P (1998) Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier. J Control Release 56: 23-32.
37. Qian ZM, Li H, Sun H, Ho K (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54: 561-587.
38. Ramachandran C, Fonseca HB, Jhabvala P, Escalon EA, Melnick SJ (2002) Curcumin inhibits telomerase activity through human telomerase reverse transcriptase in MCF-7 breast cancer cell line. Cancer Lett 184: 1-6.
39. Reddy LH, Murthy RSR (2004) Influence of polymerization technique and experimental variables on the particle properties and release kinetics of methotrexate from poly(butylcyanoacrylate) nanoparticles. Acta Pharma 54: 103-118.
40. Sahoo SK, Labhasetwar V (2005) Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm 2: 373-383.
41. Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: the story so far. Eur J Cancer 41: 1955-1968.
42. Singh S, Aggarwal BB (1995) Activation of transcription factor NF-kB is suppressed by curcumin (diferulolylmethane). J Biol Chem 270: 24995-25000.
43. Skommer J, Wlodkowic D, Pelkonen J (2006) Cellular foundation of curcumin-induced apoptosis in follicular lymphoma cell lines. Exp Hematol 34: 463-474.
44. Thangapazham RL, Sharma A, Maheshwari RK (2006) Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J 8: E443-E449.
45. 2 coated nanoparticles. PLoS One 7(5): e38129.
46. Tiyaboonchaia W, Tungpradita W, Plianbangchang P (2007) Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 337: 299-306.
47. Ulbrich K, Hekmatara T, Herbert E, Kreuter J (2009) Transferrin and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm 71: 251-256.
48. Veldhoen S, Laufer SD, Restle T (2008) Recent developments in peptide-based nucleic acid delivery. Int J Mol Sci 9: 1276-1320.
49. Vermes I, Haanen C, Reutelingsperger C (2000) Flow cytometry of apoptotic cell death. J Immuno Methods 243: 167-190.
50. Wang H, Joseph JA (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27: 612-616.
51. Wang F, Jiang X, Yang DC, Elliott RL, Head JF (2000) Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells. Anticancer Res 20: 799-808.
52. Weir NM, Selvendiran K, Kutala VK (2007) Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 6: 178-184.
53. Widera A, Norouziyan F, Shen WC (2003) Mechanisms of Tfr-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery. Adv Drug Deliv Rev 55: 1439-1466.
54. Yang X, Koh CG, Liu S (2009) Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against bcl-2. Mol Pharm 6: 221-230.